Qiagen N.V.

Qiagen N.V. is a global life sciences company specializing in molecular diagnostics and sample preparation technologies. As a public limited liability company headquartered in the Netherlands, Qiagen focuses on delivering "Sample to Insight" solutions that enable researchers, clinical laboratories, and pharmaceutical firms to extract and interpret DNA, RNA, and protein data from biological samples. The company’s product portfolio includes more than 500 core consumable products—such as sample and assay kits—automated instruments, and advanced bioinformatics software, collectively serving applications in molecular biology, disease detection, and personalized medicine. Qiagen’s technologies are widely adopted across healthcare, academic research, and pharmaceutical development sectors, supporting critical activities ranging from basic genetic research to infectious disease diagnostics, including COVID-19 testing solutions. The company’s substantial role in advancing molecular analysis has positioned it as a significant component of various global stock indices, underscoring its market importance and reach within the biotechnology and healthcare industries.